-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens on FDA CRL
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) PT Raised to $115 at Citizens AFter Q1 Results
-
-
-
-
-
-
-
Lantheus receives FDA tentative approval for generic cancer drug
-
-
-
-
-
-
-
Truist Securities Upgrades Lantheus Holdings (LNTH) to Buy
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) PT Lowered to $80 at TD Cowen
-
-
-
-
-
-
-
Lantheus gets FDA acceptance for new PSMA imaging agent formulation
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Completes Acquisition of Evergreen Theragnostics
-
439,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

